Prostate Cancer Prevention Study Shows No Benefit for Use of Selenium and Vitamin E

Initial, independent review of study data from 35,000 men 50 and older from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI), shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer over a five year period.

Bonnie - I cannot acknowledge any result from this study because it was flawed from the beginning:

1. 200 mcg. selenium is a very small dose when gauging therapeutic value. Regardless, it is intended to be a complementary trace mineral for prostate health because it cannot be taken in large amounts due to toxicity issues.
   
   
2. The vitamin E used in the trial was 400IU dl-alpha tocopherol, which is a synthetic form of vitamin E. Anyone knowledgeable health professional understands that synthetic E is worthless. In addition, most positive vitamin E research has predominately used mixed tocopherols, which compromises alpha, beta, gamma, and delta tocopherols; not just alpha alone. It has long been known that all four tocopherols need to work in unison for optimum effectiveness.

Will we see or hear about these two humongous flaws in the study? Probably not.